ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts (2017) 50 CMW4.2 | DOI: 10.1530/endoabs.50.CMW4.2

Molecular mechanisms of Graves' Orbitopathy

Mohd Shazli Draman

Cardiff University, Cardiff, United Kingdom.

Graves’ orbitopathy (GO) or thyroid eye disease (TED) is an autoimmune condition most common in people with hyperthyroid Graves’ disease. Severe GO may cause blindness due to optic compression following expansion of the orbital contents. In many patients, the persistent disfigured appearance of the eyes is a source of significant psychological distress and effective treatments are lacking. This has driven efforts to identify novel therapeutic options resulting in progress in our understanding of the tissue remodelling processes underpinning GO. In this lecture, I will describe briefly clinical aspects of GO including signs and symptoms and risk factors. I will explore GO pathogenesis including target autoantigens, regulation of tissue remodelling and tolerance mechanisms. I will also summarise recent trials of non-immunosuppressive therapies in GO.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts